APC loss via somatic truncation mutation, deletion, and promoter hypermethylation is common in several human malignancies, including colorectal cancer (CRC), breast and non-small cell lung cancer (NSCLC) [75,76,81]. The gene discussed is APC; the disease is non-small cell lung carcinoma.